• resources 2016
  • video series 2016
  • memory 2016
  • AMS Congress 2016
  • info-sheets-2016

Menopause Essentials UpdateMenopause Essentials Update for Health Professionals 
28 July 2016 - Hotel Grand Chancellor, Hobart
Menopause: What is it? | How to manage menopause | Risks and benefits of HRT | Troubleshooting HRT, low libido and testosterone Learn more... 

What's New?

  • Members update

    Changes Magazine; Eating disorders in midlife women;  Hormone therapy and large bowel cancer revisited;  NAMS Information Update on Fractional Laser Treatment for VVA;  Are women suffering in silence? - UK survey; The FDA Off...
  • Sorry folks, we were wrong at the time

    18 April 2016:  Despite the availability of effective hormonal and non-hormonal treatments for menopausal symptoms, few women with these symptoms are evaluated or treated   Whoever can download from The New England Journal of Medicin...
  • Endocrine Society encourages clinicians to avoid prescribing compounded hormones

    A new Scientific Statement issued by the Endocrine Society advises clinicians to avoid using compounded hormone medications to treat menopausal symptoms, female sexual dysfunction and other hormone conditions. Sometimes called bioidentical compounde...
  • Menopause - AWW April 2016 Why just 8 % on hrt

    The Australian Women’s Weekly April 2016 edition features four page article: Is HRT safe? Over the past 14 years, the number of Australian women using hormone replacement therapy has plummeted amid fears of a heightened risk of breast cancer. Is ...
  • Health and Social Media: are there benefits?

    Twitter, Facebook and other social media platforms can be useful tools for helping patients with rare medical diseases exchange knowledge and build communities, research from the University of Leicester has found. Patient experiences shared on digit...
  • Midlife ADHD in women: any relevance to menopause?

    12 October, 2015:  Some cognitive decline, particularly in the domains of executive functions, is common among menopausal women. A new study has examined the effect of the psychostimulant lisdexamfetamine (LDX) on subjective and objective cogni...
  • Late peri/postmenopausal women have greater cardiovascular fat

    28 September, 2015:  Growing evidence suggests a role of cardiovascular fat (epicardial + paracardial + aortic) in the pathogenesis of coronary heart disease. In order to study the relationship between deposits of cardiovascular fat and the men...

Features

  • Know your bones

    Bone fracture risk assessment:  An Australian-first bone health self-assessment tool designed to help consumers understand their bone fracture risk has been produced by Osteoporosis Australia and Garvan Institute of Medical Research. www.knowy...
  • Menopause Essentials Update

    28 July 2016:  Topics The workshop is aimed at all GPs, specialists and allied health workers who are seeking a comprehensive update in the field of menopause. Prof Bronwyn Stuckey and Dr Jane Elliott will be presenting and providing...
  • Women with Low Libido: Who Not to Treat with Testosterone?

    Professor Davis explains how to best approach testosterone therapy for women.  Professor Susan Davis is an AMS Member and a leading women's health researcher. In 2005 she became the inaugural Chair of Women's Health in the Monash University ...
  • Progestins

    Not all progestins are the same:  A/Prof John Eden is a gynaecologist and reproductive endocrinologist. His research interests include managing menopause after breast cancer, polycystic ovarian syndrome, osteoporosis, hormone replacement ther...
  • Compounded Bioidentical Hormones in Endocrinology Practice

    Custom compounded hormone therapy might seem attractive to your patient but the recent statement from the US Endocrine Society sounds a warning! This scientific statement finds that there is no rationale for prescribing of unregulated, untested,...
  • Early use of postmenopausal hormone therapy may prevent heart disease

    Findings suggest that after decades of research regarding the effectiveness of MHT on heart disease, timing may be everything:  Hormone therapy, when taken within six years of menopause, may slow the progression of subclinical atherosclerosis, ...
  • The Use of Vaginal Estrogen in Women with a History of Estrogen-Dependent Breast Cancer

    In a new Committee Opinion, "The Use of Vaginal Estrogen in Women with a History of Estrogen-Dependent Breast Cancer," the American College of Obstetricians and Gynecologists (ACOG) outlines the options and treatments for female-specific survivorship...
cialis